Table 7.
Fatty acid (g/100 g total fatty acids) | Subcutaneous adipose tissue1 | Intramuscular adipose tissue | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
Control | Palm oil | Soybean oil | SEM | p-value | Control | Palm oil | Soybean oil | SEM | p-value | |
16:02 | 27.91 | 26.95 | 26.70 | 0.37 | 0.09 | 31.88 | 32.22 | 31.43 | 0.19 | 0.14 |
16:1n-73 | 5.00a | 3.73b | 4.30ab | 0.24 | 0.05 | 3.66 | 3.32 | 3.62 | 0.15 | 0.10 |
18:02 | 10.43b | 12.55a | 12.58a | 0.54 | 0.02 | 14.72 | 15.00 | 14.82 | 0.47 | 0.39 |
18:1n-93 | 42.94 | 42.70 | 42.85 | 0.60 | 0.22 | 34.92 | 35.91 | 35.03 | 0.54 | 0.26 |
18:1n-73 | 1.83a | 1.36b | 1.46b | 0.07 | 0.01 | 0.97a | 0.50b | 0.66ab | 0.09 | 0.04 |
18:2n-6 | 1.84 | 1.90 | 2.04 | 0.08 | 0.18 | 1.67 | 1.63 | 1.88 | 0.07 | 0.10 |
18:3n-33 | 0.08 | 0.07 | 0.10 | 0.01 | 0.22 | 0.02 | 0.01 | 0.01 | 0.01 | 0.17 |
18:2cis-9, trans-113 | 0.67 | 0.60 | 0.65 | 0.04 | 0.25 | 0.04 | 0.04 | 0.01 | 0.02 | 0.17 |
AMPKα | 2.78a | 2.19b | 2.46ab | 0.25 | 0.04 | 2.16 | 1.93 | 1.84 | 0.21 | 0.31 |
CEBPβ | 1.63ab | 1.14b | 2.72a | 0.35 | 0.03 | 1.51ab | 0.74b | 1.98a | 0.41 | 0.01 |
GPR43 | 2.99 | 3.83 | 3.08 | 0.92 | 0.24 | 3.50 | 4.89 | 1.65 | 1.06 | 0.17 |
PPARγ3 | 1.00 | 1.26 | 1.02 | 0.21 | 0.31 | 0.58 | 0.43 | 0.41 | 0.09 | 0.25 |
SCD3 | 1.85a | 1.04ab | 0.66b | 0.14 | 0.05 | 0.08 | 0.13 | 0.04 | 0.03 | 0.16 |
SEM, standard error of the mean; AMPKα, AMP-activated protein kinase alpha; CEBPβ, CCAAT enhancer binding protein-β; GPR43, G-coupled protein receptor 43; PPARγ, peroxisome proliferator-activated receptor gamma; SCD, stearoyl-CoA desaturase.
Data for subcutaneous adipose tissue derived from Choi et al. (2013).
Intramuscular adipose tissue > subcutaneous adipose tissue, p<0.05 (data pooled across dietary treatments).
Intramuscular adipose tissue < subcutaneous adipose tissue, p<0.05 (data pooled across dietary treatments).
Means in rows not bearing a common superscript differ, p<0.05.